When was Tissuemed founded?

Tissuemed was founded in 1985 and raised its 1st funding round 14 years after it was founded.

Where is Tissuemed located?

Tissuemed is headquartered in Leeds, United Kingdom.

How many employees does Tissuemed have?

As of Mar 31, 2022, the latest employee count at Tissuemed is 19.

Is Tissuemed a funded company?

Tissuemed is a funded company, having raised a total of $12.7M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 01, 1999.

When was the latest funding round of Tissuemed?

Tissuemed's latest funding was a $***** Grant (prize money) round on Nov 30, 2015, with participation from 1 investor. Its primary sector is Surgical Instruments. In United Kingdom, the Surgical Instruments sector has seen $12.1M in funding in 2026 to date.

Where does Tissuemed rank among its competitors?

Tissuemed ranks 5th amongst 21 active competitors, of which 10 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was TYBR Health, which secured $30M in Jul, 2026.

Who are the top competitors of Tissuemed?

Tissuemed's top competitors include TYBR Health, Cousin Surgery and Neomend. Among them, TYBR Health secured the most recent funding round in July, 2026.

Tissuemed - 2026 Company Profile, Team, Funding & Competitors

Tissuemed is an acqui-hired company based in Leeds (United Kingdom), founded in 1985. It operates as a Bioadhesive films to prevent body fluid and air leakage during surgery. Tissuemed has raised $12.7M in funding. The company has 21 active competitors, including 10 funded and 3 that have exited. Its top competitors include companies like TYBR Health, Cousin Surgery and Neomend.

Company Details

Tissuemed develops and markets synthetic, self-adhesive, bioadhesive films to prevent air, blood, CSF and other fluid leaks encountered in surgery. All products incorporate a patented polymer on one side that bonds to tissue surfaces. The other surface is non-adhesive, providing favourable structural characteristics, ease of handling and potentially preventing post-surgical adhesions. TissuePatch films are ultimately resorbable and, reassuringly, based on polymers commonly used in other implants. Flagship product TissuePatchDural is used for prevention of CSF leaks in Neuro and Spinal surgery when the Dura Mater has been breached. Tissuemed has been granted regulatory approval of its TissuePatch range of ultra-thin surgical sealant films by Chinese FDA.

Website: tissuemed.com
Social
Email ID: *****@tissuemed.com

Key Metrics

Founded Year

1985

Location

Leeds, United Kingdom

Stage

Acqui-Hired

Total Funding

$12.7M in 6 rounds

Latest Funding Round

Grant (prize money), Nov 30, 2015, $*****

Investors

Saints Capital & 6 more

Ranked

5^th among 21 active competitors

Employee Count

19 as on Mar 31, 2022

Similar Companies

TYBR Health & 25 more

View Tissuemed's full profile

Tissuemed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Tissuemed Limited CIN: 1902503 , Germany, Active		-	19 (As on Mar 31, 2022)

Tissuemed has raised a total funding of $12.7M over 6 rounds. Its first funding round was on May 01, 1999. Its latest funding round was a Grant (prize money) round on Nov 30, 2015 for $*****. 1 investor participated in its latest round. Tissuemed has 7 institutional investors.

Here is the list of recent funding rounds of Tissuemed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 30, 2015	4340758	Grant (prize money)	9858465	9124853	2763709	6589525
Jul 15, 2015	6805993	Grant (prize money)	9979690	8679478	6524171	Gov
Jun 01, 2015	6524431	Grant (prize money)	3947757	1853867	8470448	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Tissuemed's funding rounds and investors

Here are the details of Tissuemed's key team members:

David Mandley: CEO of Tissuemed. They serve on the board of 1 company.

Tissuemed's Board of Directors

Tissuemed's board has 5 active members. Michael Henderson is part of team and Ian Thompson, Jeremy David Sampson, Paul Lancelot Banner and Peter Maver are independent board members.

Here is the list of Tissuemed's board of directors:

Name	Type	Representing	Status	Duration
Michael Henderson	Team	-	Current	32y 10m
Ian Thompson	Independent board member	-	Current	8y 5m
npoicuc	Independent board member	-	Current	9y 8m
zfkcoal	Independent board member	-	Current	3y 8m
qg{sdsi	Independent board member	-	Current	4y 5m
mcowiwv	Independent board member	-	Past	2y 5m
lijxcly	Independent board member	-	Past	4y 3m
cptbxpv	Independent board member	-	Past	7y 8m
mhnrkhw	Independent board member	-	Past	5y 1m
elztwsr	Independent board member	-	Past	6y 2m
dzyvspb	Independent board member	-	Past	8y 7m
cyqrpvn	Independent board member	-	Past	9y 4m
tmugpvc	Independent board member	-	Past	9y 9m
nmqxucb	Independent board member	-	Past	5y 9m
txxywnp	Independent board member	-	Past	1y 1m
lisesil	Independent board member	-	Past	3y 3m
mkzzkqb	Independent board member	-	Past	4y 7m
fufbqcw	Independent board member	-	Past	1y 6m
nvjbttm	Independent board member	-	Past	8y 2m
bl{dqsp	Independent board member	-	Past	6y 7m
troqoyx	Independent board member	-	Past	4y 5m
{zphbzk	Independent board member	-	Past	2y 2m
sqicwqd	Independent board member	-	Past	3y 9m
kidjqss	Independent board member	-	Past	6y 6m
piuwutq	Independent board member	-	Past	9y 8m
voioiuv	Independent board member	-	Past	1y 2m
wehawap	Independent board member	-	Past	1y 9m
{mzdnva	Independent board member	-	Past	7y 9m

View details of Tissuemed's Founder profiles and Board Members

Tissuemed's employee count trend

Tissuemed has 19 employees as of Mar 22. The total employee count is 6.0% more than what it was in Mar 21. Here is Tissuemed's employee count trend over the years:

Uncover Tissuemed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Tissuemed include TYBR Health, Cousin Surgery and Neomend. Here is the list of Top 10 competitors of Tissuemed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TYBR Health 2020, Houston (United States), Series A	Provider of regenrative medicine for post surgical scarring	$38.4M	Vensana Capital, Y Combinator & 4 others	56/100
2nd	Cousin Surgery 1848, Wervicq Sud (France), Unfunded	Manufacturer of implantable textile medical devices for spine and visceral surgery. It develops innovative implants to advance visceral and spine surgery, focusing on preserving mobility and reducing post-operative pain. The company collaborates closely with surgeons and utilizes unique expertise in implantable textiles. Its product portfolio includes solutions for various surgical specialties, such as orthopedics, uro-gynecology, and bariatric surgery, along with adhesion prevention and hemostasis products. The company also offers subcontracting services and technological support.	-	Turenne Groupe, Nord Capital Partenaires	45/100
3rd	Neomend 1999, Irvine (United States), Acquired	Provider of air leak sealant for thoracic surgery	$38.8M	Vivo Capital, Novo Holdings & 4 others	43/100
4th	Sylke 2023, La Jolla (United States), Series B	Provider of medical device company	$15.5M	Vaark	40/100
5th	Tissuemed 1985, Leeds (United Kingdom), Acqui-Hired	Bioadhesive films to prevent body fluid and air leakage during surgery	$12.7M	Saints Capital, Shackleton Ventures & 5 others	39/100
6th	GATT Technologies BV 2011, Nijmegen (Netherlands), Series B	Polymer-based General Adhesive Tissue Tape	$11.4M	EIC Fund, Johnson & Johnson Innovation & 3 others	38/100
7th	BioDevek 2014, Boston (United States), Funding Raised	Developer of next generation of surgical sealant solutions	-	MedTech Innovator, National Science Foundation ... & 1 others	37/100
8th	Clozex 2003, Wellesley (United States), Series A	Innovative skin closure devices for advanced wound care and surgical solutions	$4.48M	-	37/100
9th	Sealonix 2023, Bedford (United States), Series A	Developer of hemostatic sealants for surgeries	$20M	Excelestar Ventures, AMED Ventures & 4 others	35/100
10th	Cohera Medical 2006, Pittsburgh (United States), Deadpooled	Developer of surgical adhesives and sealants	$136M	KKR, H.I.G. Private Equity & 5 others	35/100